Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This proposed phase II trial will investigate the combination of topotecan/carboplatin in the
first-line treatment of patients with extensive-stage SCLC. Topotecan/platinum regimens are
emerging as common treatments for patients with extensive-stage disease. This trial will be
one of the first clinical trials to evaluate a combination of weekly topotecan and
carboplatin in the first-line treatment of extensive-stage SCLC.